ViewMind is a digital health and artificial intelligence company that is reshaping the landscape of cognitive solutions. Their mission is to foster personal growth and unlock new realms of possibilities through their clinically validated solutions for precision assessment of neurocognitive disorders. Utilizing their groundbreaking technology, ViewMind measures the state of 16 cognitive domains and 19 brain-related regions using ocular digital phenotyping.

This innovative approach delivers unmatched levels of accuracy and correlates with biomarkers, neuroimaging, and EEG. Founded on 20 years of scientific research led by Dr. Gerardo Fernandez, ViewMind has collaborated with academic institutions, hospitals, research facilities, key opinion leaders, and pharmaceutical companies to continuously test and refine their breakthrough technology.

In addition, ViewMind is actively seeking partnerships for commercial pharmaceutical studies, commercialization, and new studies with clinical centers and patient advocacy groups. With a team of neuroscientists, engineers, and data scientists, ViewMind is poised to revolutionize the field of cognitive health